Mini E - Search Results

1

Inhibition of MDR1 gene expression by antimessenger oligonucleotides lowers multiple drug resistance.

Quattrone A, Papucci L, Morganti M, Coronnello M, Mini E, Mazzei T, Colonna FP, Garbesi A, Capaccioli S. Quattrone A, et al. Among authors: mini e. Oncol Res. 1994;6(7):311-20. Oncol Res. 1994. PMID: 7865906

2

[Relation of pharmacokinetics and toxicity of methotrexate at high dose].

Mini E, Mazzei T, Ciuffi M, Ruggeri M, Benini A, Carniani E. Mini E, et al. G Ital Chemioter. 1979 Jan-Dec;26(1-2):387-96. G Ital Chemioter. 1979. PMID: 318004 Italian. No abstract available.

3

Pharmacokinetic drug interactions of macrolides.

Periti P, Mazzei T, Mini E, Novelli A. Periti P, et al. Among authors: mini e. Clin Pharmacokinet. 1992 Aug;23(2):106-31. doi: 10.2165/00003088-199223020-00004. Clin Pharmacokinet. 1992. PMID: 1511528 Review.

4

Chromosomal characterization of methotrexate-resistant human T-lymphoblast leukemia cells (CCRF-CEM) with impaired polyglutamylation.

Mini E, Stanyon R, Coronnello M, Gerli A, Mazzei T, Periti P. Mini E, et al. Tumori. 1991 Apr 30;77(2):95-9. doi: 10.1177/030089169107700201. Tumori. 1991. PMID: 2048234

5

Leuprorelin acetate depot in advanced prostatic cancer: a phase II multicentre trial.

Rizzo M, Mazzei T, Mini E, Bartoletti R, Periti P. Rizzo M, et al. Among authors: mini e. J Int Med Res. 1990;18 Suppl 1:114-25. doi: 10.1177/03000605900180S116. J Int Med Res. 1990. PMID: 2108883 Clinical Trial.

6

Human pharmacokinetic and pharmacodynamic profiles of leuprorelin acetate depot in prostatic cancer patients.

Mazzei T, Mini E, Rizzo M, Periti P. Mazzei T, et al. Among authors: mini e. J Int Med Res. 1990;18 Suppl 1:42-56. doi: 10.1177/03000605900180S108. J Int Med Res. 1990. PMID: 2108885 Clinical Trial.

7

Biochemical modulation of fluoropyrimidines by antifolates and folates in an in vitro model of human leukemia.

Mini E, Coronnello M, Carotti S, Gerli A, Pesciullesi A, Moroson BA, Mazzei T, Periti P, Bertino JR. Mini E, et al. J Chemother. 1990 Feb;2 Suppl 1:17-27. doi: 10.1080/1120009x.1990.11739000. J Chemother. 1990. PMID: 2142214 Review.

8

Impaired polyglutamylation of methotrexate as a cause of resistance in CCRF-CEM cells after short-term, high-dose treatment with this drug.

Pizzorno G, Mini E, Coronnello M, McGuire JJ, Moroson BA, Cashmore AR, Dreyer RN, Lin JT, Mazzei T, Periti P, et al. Pizzorno G, et al. Among authors: mini e. Cancer Res. 1988 Apr 15;48(8):2149-55. Cancer Res. 1988. PMID: 2450647

9

Impaired methotrexate polyglutamylation in a human leukemia cell line resistant to short-term, high-dose methotrexate.

Mini E, Pizzorno G, Coronnello M, McGuire JJ, Mazzei T, Periti P, Bertino JR. Mini E, et al. Pharmacol Res Commun. 1988 May;20(5):445-6. doi: 10.1016/s0031-6989(88)80035-3. Pharmacol Res Commun. 1988. PMID: 2458604 No abstract available.

10

Pharmacokinetics, endocrine and antitumour effects of leuprolide depot (TAP-144-SR) in advanced prostatic cancer: a dose-response evaluation.

Mazzei T, Mini E, Eandi M, Reali EF, Fioretto L, Bartoletti R, Rizzo M, Calabrò G, Periti P. Mazzei T, et al. Among authors: mini e. Drugs Exp Clin Res. 1989;15(8):373-87. Drugs Exp Clin Res. 1989. PMID: 2513176

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

248 results

Search Page

Filters